{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T20:33:50Z","timestamp":1794083630683,"version":"4.8.0"},"reference-count":257,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T00:00:00Z","timestamp":1734566400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Polycystic ovary syndrome (PCOS) is a prevalent endocrine and metabolic disorder affecting 6-20% of women of childbearing age worldwide. Immune cell imbalance and dysregulation of inflammatory factors can lead to systematic low-grade chronic inflammation (SLCI), which plays a pivotal role in the pathogenesis of PCOS. A significant higher infiltration of immune cells such as macrophages and lymphocytes and pro-inflammatory factors IL-6 and TNF-\u03b1 has been detected in PCOS organ systems, impacting not only the female reproductive system but also other organs such as the cardiovascular, intestine, liver, thyroid, brain and other organs. Obesity, insulin resistance (IR), steroid hormones imbalance and intestinal microecological imbalance, deficiencies in vitamin D and selenium, as well as hyperhomocysteinemia (HHcy) can induce systematic imbalance between pro-inflammatory and anti-inflammatory cells and molecules. The pro-inflammatory cells and cytokines also interact with obesity, steroid hormones imbalance and IR, leading to increased metabolic imbalance and reproductive-endocrine dysfunction in PCOS patients. This review aims to summarize the dysregulation of immune response in PCOS organ system and the intrinsic mechanisms affecting SLCI in PCOS to provide new insights for the systemic inflammatory treatment of PCOS in the future.<\/jats:p>","DOI":"10.3389\/fimmu.2024.1470283","type":"journal-article","created":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T05:10:20Z","timestamp":1734585020000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":130,"title":["Systematic low-grade chronic inflammation and intrinsic mechanisms in polycystic ovary syndrome"],"prefix":"10.3389","volume":"15","author":[{"given":"Hongxia","family":"Deng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jilong","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nannan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liangzhi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,12,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2003-032046","article-title":"The prevalence and features of the polycystic ovary syndrome in an unselected population","volume":"89","author":"Azziz","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1080\/09513590.2022.2121387","article-title":"Are there new insights for the definition of PCOS","volume":"38","author":"Baracat","year":"2022","journal-title":"Gynecol Endocrinol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2018.24","article-title":"Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment","volume":"14","author":"Escobar-Morreale","year":"2018","journal-title":"Nat Rev Endocrinol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1007\/s11154-016-9326-7","article-title":"Polycystic ovary syndrome (PCOS) and endocrine disrupting chemicals (EDCs)","volume":"16","author":"Palioura","year":"2015","journal-title":"Rev Endocr Metab Disord"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-3886","article-title":"The potential implications of a PCOS diagnosis on a woman\u2019s long-term health using data linkage","volume":"100","author":"Hart","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2018.5188","article-title":"Association between polycystic ovary syndrome and cancer risk","volume":"5","author":"Yin","year":"2019","journal-title":"JAMA Oncol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph19031336","article-title":"Polycystic ovary syndrome: an evolutionary adaptation to lifestyle and the environment","volume":"19","author":"Parker","year":"2022","journal-title":"Int J Environ Res Public Health"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1169232","article-title":"Dysregulation of immune response in PCOS organ system","volume":"14","author":"Wang","year":"2023","journal-title":"Front Immunol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jri.2022.103628","article-title":"Systemic and ovarian inflammation in women with polycystic ovary syndrome","volume":"151","author":"Zhai","year":"2022","journal-title":"J Reprod Immunol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.123.065827","article-title":"Polycystic ovary syndrome fuels cardiovascular inflammation and aggravates ischemic cardiac injury","volume":"148","author":"Gao","year":"2023","journal-title":"Circulation"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-021-00639-3","article-title":"Immune cell-mediated features of non-alcoholic steatohepatitis","volume":"22","author":"Huby","year":"2022","journal-title":"Nat Rev Immunol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v20.i39.14172","article-title":"Review of nonalcoholic fatty liver disease in women with polycystic ovary syndrome","volume":"20","author":"Kelley","year":"2014","journal-title":"World J Gastroenterol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.2147\/JIR.S260770","article-title":"Peripheral blood inflammatory-immune cells as a predictor of infertility in women with polycystic ovary syndrome","volume":"13","author":"He","year":"2020","journal-title":"J Inflammation Res"},{"key":"B14","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s40618-015-0335-2","article-title":"The mean platelet volume and neutrophil to lymphocyte ratio in obese and lean patients with polycystic ovary syndrome","volume":"39","author":"Yilmaz","year":"2016","journal-title":"J Endocrinol Invest"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejogrb.2011.07.012","article-title":"Low-grade chronic inflammation in the peripheral blood and ovaries of women with polycystic ovarian syndrome","volume":"159","author":"Xiong","year":"2011","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1210\/jc.2004-0628","article-title":"The increase of leukocytes as a new putative marker of low-grade chronic inflammation and early cardiovascular risk in polycystic ovary syndrome","volume":"90","author":"Orio","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"B17","doi-asserted-by":"publisher","first-page":"C375","DOI":"10.1152\/ajpcell.00379.2020","article-title":"Adipose tissue inflammation and metabolic dysfunction in obesity","volume":"320","author":"Kawai","year":"2021","journal-title":"Am J Physiol Cell Physiol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22073789","article-title":"Chronic low grade inflammation in pathogenesis of PCOS","volume":"22","author":"Rudnicka","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jri.2020.103155","article-title":"Role of IL-6 signalling in Polycystic Ovarian Syndrome associated inflammation","volume":"141","author":"Borthakur","year":"2020","journal-title":"J Reprod Immunol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1177\/1179558119861936","article-title":"The possible practical implication of high CRP levels in PCOS","volume":"13","author":"Blumenfeld","year":"2019","journal-title":"Clin Med Insights Reprod Health"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/s0739-7240(96)00094-x","article-title":"Potential roles of tumor necrosis factor-alpha in follicular development, ovulation, and the life span of the corpus luteum","volume":"14","author":"Terranova","year":"1997","journal-title":"Domest Anim Endocrinol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7827-9-7","article-title":"Is interleukin-18 associated with polycystic ovary syndrome","volume":"9","author":"Yang","year":"2011","journal-title":"Reprod Biol Endocrinol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"91","DOI":"10.14310\/horm.2002.1563","article-title":"White blood cells levels and PCOS: direct and indirect relationship with obesity and insulin resistance, but not with hyperandogenemia","volume":"14","author":"Papalou","year":"2015","journal-title":"Hormones (Athens)"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.787876","article-title":"IL-15 participates in the pathogenesis of polycystic ovary syndrome by affecting the activity of granulosa cells","volume":"13","author":"Liu","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0235404","article-title":"The role of serum inflammatory cytokines and berberine in the insulin signaling pathway among women with polycystic ovary syndrome","volume":"15","author":"Kuang","year":"2020","journal-title":"PloS One"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1007\/s00011-017-1045-3","article-title":"Association of IL-1\u03b2, IL-1Ra and FABP1 gene polymorphisms with the metabolic features of polycystic ovary syndrome","volume":"66","author":"Rashid","year":"2017","journal-title":"Inflammation Res"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000030579","article-title":"Association between neutrophil-to-lymphocyte ratio and polycystic ovary syndrome: A PRISMA-compliant systematic review and meta-analysis","volume":"101","author":"Li","year":"2022","journal-title":"Med (Baltimore)"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1177\/03000605211067316","article-title":"Mean platelet volume and polycystic ovary syndrome: a systematic review and meta-analysis","volume":"50","author":"Li","year":"2022","journal-title":"J Int Med Res"},{"key":"B29","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1186\/s13048-023-01236-9","article-title":"Opportunities and challenges: interleukin-22 comprehensively regulates polycystic ovary syndrome from metabolic and immune aspects","volume":"16","author":"Geng","year":"2023","journal-title":"J Ovarian Res"},{"key":"B30","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1111\/j.1365-2265.2004.02170.x","article-title":"Increased levels of serum advanced glycation end-products in women with polycystic ovary syndrome","volume":"62","author":"Diamanti-Kandarakis","year":"2005","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1111\/aji.13407","article-title":"Association of circulating monocyte chemoattractant protein-1 levels with polycystic ovary syndrome: A meta-analysis","volume":"86","author":"Wu","year":"2021","journal-title":"Am J Reprod Immunol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1007\/s13224-023-01897-y","article-title":"Evaluation of CRP\/albumin ratio in polycystic ovarian syndrome","volume":"74","author":"Upadhyay","year":"2024","journal-title":"J Obstet Gynaecol India"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.jri.2021.103282","article-title":"Evaluation of endometrial immune status of polycystic ovary syndrome","volume":"144","author":"Liu","year":"2021","journal-title":"J Reprod Immunol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2019.11.003","article-title":"Polycystic ovarian syndrome: Correlation between hyperandrogenism, insulin resistance and obesity","volume":"502","author":"Zeng","year":"2020","journal-title":"Clin Chim Acta"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1055\/s-0035-1554928","article-title":"Inflammation and human ovarian follicular dynamics","volume":"33","author":"Boots","year":"2015","journal-title":"Semin Reprod Med"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.jri.2020.103083","article-title":"IL-18 and IL-18 binding protein concentration in ovarian follicular fluid of women with unexplained infertility to PCOS during in vitro fertilization","volume":"138","author":"Zhang","year":"2020","journal-title":"J Reprod Immunol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2014.09.002","article-title":"Granulocyte colony-stimulating factor: A relation between serum and follicular fluid levels and in-vitro fertilization outcome in patients with polycystic ovary syndrome","volume":"74","author":"Kahyaoglu","year":"2015","journal-title":"Cytokine"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.111711","article-title":"The therapeutic effect of anti-CD19 antibody on DHEA-induced PCOS mice","volume":"130","author":"Wang","year":"2024","journal-title":"Int Immunopharmacol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2022.108717","article-title":"Gut microbiota dysbiosis-derived macrophage pyroptosis causes polycystic ovary syndrome via steroidogenesis disturbance and apoptosis of granulosa cells","volume":"107","author":"Huang","year":"2022","journal-title":"Int Immunopharmacol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3109\/01674820309042802","article-title":"Elevated serum TNF-alpha levels in normal-weight women with polycystic ovaries or the polycystic ovary syndrome","volume":"48","author":"Sayin","year":"2003","journal-title":"J Reprod Med"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/s0029-7844(03)00233-3","article-title":"Serum and follicular fluid cytokines in polycystic ovary syndrome during stimulated cycles","volume":"101","author":"Amato","year":"2003","journal-title":"Obstet Gynecol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/s0015-0282(16)55438-7","article-title":"Tumor necrosis factor alpha in the human ovary: presence in follicular fluid and effects on cell proliferation and prostaglandin production","volume":"58","author":"Wang","year":"1992","journal-title":"Fertil Steril"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-71-5-1096","article-title":"Immunological evidence for a human ovarian tumor necrosis factor-alpha","volume":"71","author":"Roby","year":"1990","journal-title":"J Clin Endocrinol Metab"},{"key":"B44","article-title":"Expression of mRNAs encoding tumor necrosis factor-alpha and its receptor-I in buffalo ovary","volume":"45","author":"MadhuSudan","year":"2007","journal-title":"Indian J Exp Biol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-291X(02)00431-X","article-title":"Induction of apoptosis in granulosa cells by TNF alpha and its attenuation by glucocorticoids involve modulation of Bcl-2","volume":"294","author":"Sasson","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1007\/s10815-016-0704-6","article-title":"Follicular fluid soluble receptor for advanced glycation endproducts (sRAGE): a potential protective role in polycystic ovary syndrome","volume":"33","author":"Wang","year":"2016","journal-title":"J Assist Reprod Genet"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0897.2011.01059.x","article-title":"Interleukin-6 as an early chronic inflammatory marker in polycystic ovary syndrome with insulin receptor substrate-2 polymorphism","volume":"66","author":"Lin","year":"2011","journal-title":"Am J Reprod Immunol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0148531","article-title":"Interleukin-6 levels in women with polycystic ovary syndrome: A systematic review and meta-analysis","volume":"11","author":"Peng","year":"2016","journal-title":"PloS One"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2004.12.014","article-title":"Reduction of estrogen production by interleukin-6 in a human granulosa tumor cell line may have implications for endometriosis-associated infertility","author":"Deura","year":"2005","journal-title":"Fertil Steril"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.685724","article-title":"The release of peripheral immune inflammatory cytokines promote an inflammatory cascade in PCOS patients via altering the follicular microenvironment","volume":"12","author":"Liu","year":"2021","journal-title":"Front Immunol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1023\/a:1009495913119","article-title":"Relationships between concentrations of tumor necrosis factor-alpha and nitric oxide in follicular fluid and oocyte quality","volume":"17","author":"Lee","year":"2000","journal-title":"J Assist Reprod Genet"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1089\/met.2006.4.122","article-title":"Association between circulating tumor necrosis factor-alpha, interleukin-6, and insulin resistance in normal-weight women with polycystic ovary syndrome","volume":"4","author":"Tarkun","year":"2006","journal-title":"Metab Syndr Relat Disord"},{"key":"B53","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1146\/annurev-pathmechdis-012418-012743","article-title":"Immunological basis for recurrent fetal loss and pregnancy complications","volume":"14","author":"Deshmukh","year":"2019","journal-title":"Annu Rev Pathol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.aat6114","article-title":"Immune responses at the maternal-fetal interface","volume":"4","author":"Ander","year":"2019","journal-title":"Sci Immunol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02317","article-title":"Dynamic function and composition changes of immune cells during normal and pathological pregnancy at the maternal-fetal interface","volume":"10","author":"Yang","year":"2019","journal-title":"Front Immunol"},{"key":"B56","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.rbmo.2016.04.006","article-title":"Low aneuploidy rate in early pregnancy loss abortuses from patients with polycystic ovary syndrome","volume":"33","author":"Wang","year":"2016","journal-title":"Reprod BioMed Online"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/dev055","article-title":"Endometrial stromal fibroblasts from women with polycystic ovary syndrome have impaired progesterone-mediated decidualization, aberrant cytokine profiles and promote enhanced immune cell migration","volume":"30","author":"Piltonen","year":"2015","journal-title":"vitro. Hum Reprod"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1097\/CM9.0000000000001214","article-title":"NLRP3 inflammasome: a new therapeutic target for high-risk reproductive disorders","volume":"134","author":"Zhou","year":"2020","journal-title":"Chin Med J (Engl)"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1093\/molehr\/gaz067","article-title":"Abnormal uterine inflammation in obstetric syndromes: molecular insights into the role of chemokine decoy receptor D6 and inflammasome NLRP3","volume":"26","author":"Tersigni","year":"2020","journal-title":"J Int Manage"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmab028","article-title":"Stanniocalcin-1 in the female reproductive system and pregnancy","volume":"27","author":"Bishop","year":"2021","journal-title":"Hum Reprod Update"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1093\/biolre\/ioz180","article-title":"Women with polycystic ovary syndrome present with altered endometrial expression of stanniocalcin-1\u2020","volume":"102","author":"Khatun","year":"2020","journal-title":"Biol Reprod"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2013-1923","article-title":"Mesenchymal stem\/progenitors and other endometrial cell types from women with polycystic ovary syndrome (PCOS) display inflammatory and oncogenic potential","volume":"98","author":"Piltonen","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1038\/ncpendmet0846","article-title":"The role of thyroid autoimmunity in fertility and pregnancy","volume":"4","author":"Poppe","year":"2008","journal-title":"Nat Clin Pract Endocrinol And Metab"},{"key":"B64","doi-asserted-by":"publisher","first-page":"R159","DOI":"10.1530\/EJE-16-0611","article-title":"MANAGEMENT OF ENDOCRINE DISEASE: The impact of subclinical hypothyroidism on anthropometric characteristics, lipid, glucose and hormonal profile of PCOS patients: a systematic review and meta-analysis","volume":"176","author":"Pergialiotis","year":"2017","journal-title":"Eur J Of Endocrinology"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1530\/EC-18-0309","article-title":"Association between PCOS and autoimmune thyroid disease: a systematic review and meta-analysis","volume":"7","author":"Romitti","year":"2018","journal-title":"Endocr Connect"},{"key":"B66","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/nrendo.2013.212","article-title":"Endocrine autoimmune diseases and female infertility","volume":"10","author":"Sen","year":"2014","journal-title":"Nat Rev Endocrinol"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.4103\/2230-8210.146860","article-title":"Thyroid disorders and polycystic ovary syndrome: An emerging relationship","volume":"19","author":"Singla","year":"2015","journal-title":"Indian J Endocrinol Metab"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph17072422","article-title":"Increased risk of polycystic ovary syndrome and it\u2019s comorbidities in women with autoimmune thyroid disease","volume":"17","author":"Ho","year":"2020","journal-title":"Int J Environ Res Public Health"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.5812\/ijem.17954","article-title":"Detection of thyroid autoimmunity markers in euthyroid women with polycystic ovary syndrome: a case-control study from Syria","volume":"12","author":"Al-Saab","year":"2014","journal-title":"Int J Endocrinol Metab"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.5468\/ogs.2017.60.2.187","article-title":"Thyroid function\/antibodies in Sudanese women with polycystic ovarian disease","volume":"60","author":"Mohammed","year":"2017","journal-title":"Obstet Gynecol Sci"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-pathol-012513-104713","article-title":"Mechanisms of autoimmune thyroid diseases: from genetics to epigenetics","volume":"9","author":"Tomer","year":"2014","journal-title":"Annu Rev Pathol"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2010.06.008","article-title":"Polycystic ovary syndrome and autoimmunity","volume":"21","author":"Petr\u00edkov\u00e1","year":"2010","journal-title":"Eur J Intern Med"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2009.11.049","article-title":"The determinants of insulin sensitivity, \u03b2-cell function, and glucose tolerance are different in patients with polycystic ovary syndrome than in women who do not have hyperandrogenism","volume":"94","author":"Luque-Ram\u00edrez","year":"2010","journal-title":"Fertil Steril"},{"key":"B74","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s12902-018-0243-5","article-title":"Comparison of glycemic control and \u03b2-cell function in new onset T2DM patients with PCOS of metformin and saxagliptin monotherapy or combination treatment","volume":"18","author":"Tao","year":"2018","journal-title":"BMC Endocr Disord"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.00510.2014","article-title":"Pancreatic \u03b2-cell dysfunction in polycystic ovary syndrome: role of hyperglycemia-induced nuclear factor-\u03baB activation and systemic inflammation","volume":"308","author":"Malin","year":"2015","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.118003","article-title":"Nanocurcumin alleviates insulin resistance and pancreatic deficits in polycystic ovary syndrome rats: Insights on PI3K\/AkT\/mTOR and TNF-\u03b1 modulations","volume":"256","author":"Abuelezz","year":"2020","journal-title":"Life Sci"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.2147\/JEP.S323962","article-title":"Nanocurcumin Modulates miR-223-3p and NF-\u03baB Levels in the Pancreas of Rat Model of Polycystic Ovary Syndrome to Attenuate Autophagy Flare, Insulin Resistance and Improve \u00df Cell Mass","volume":"13","author":"Abuelezz","year":"2021","journal-title":"J Exp Pharmacol"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics12092045","article-title":"Differentiating polycystic ovary syndrome from adrenal disorders","volume":"12","author":"Yesiladali","year":"2022","journal-title":"Diagnostics (Basel)"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1007\/s11154-007-9054-0","article-title":"The adrenal and polycystic ovary syndrome","volume":"8","author":"Yildiz","year":"2007","journal-title":"Rev Endocr Metab Disord"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.5582\/bst.2015.01154","article-title":"Dehydroepiandrosterone improves the ovarian reserve of women with diminished ovarian reserve and is a potential regulator of the immune response in the ovaries","volume":"9","author":"Zhang","year":"2015","journal-title":"Biosci Trends"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsbmb.2016.12.004","article-title":"New PCOS-like phenotype in older infertile women of likely autoimmune adrenal etiology with high AMH but low androgens","volume":"167","author":"Gleicher","year":"2017","journal-title":"J Steroid Biochem Mol Biol"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-017-1498-8","article-title":"Suspected ontogeny of a recently described hypo-androgenic PCOS-like phenotype with advancing age","volume":"59","author":"Gleicher","year":"2018","journal-title":"Endocrine"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2023.155280","article-title":"Troxerutin dampened hypothalamic neuroinflammation via microglial IL-22\/IL-22R1\/IRF3 activation in dihydrotestosterone-induced polycystic ovary syndrome rats","volume":"124","author":"Gao","year":"2024","journal-title":"Phytomedicine"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2016.05.117","article-title":"Central leptin resistance and hypothalamic inflammation are involved in letrozole-induced polycystic ovary syndrome rats","volume":"476","author":"Lian","year":"2016","journal-title":"Biochem Biophys Res Commun"},{"key":"B85","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1172\/JCI88878","article-title":"Hypothalamic inflammation in obesity and metabolic disease","volume":"127","author":"Jais","year":"2017","journal-title":"J Clin Invest"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1210\/en.2004-1520","article-title":"Consumption of a fat-rich diet activates a proinflammatory response and induces insulin resistance in the hypothalamus","volume":"146","author":"De Souza","year":"2005","journal-title":"Endocrinology"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1172\/JCI59660","article-title":"Obesity is associated with hypothalamic injury in rodents and humans","volume":"122","author":"Thaler","year":"2012","journal-title":"J Clin Invest"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1530\/JOE-14-0283","article-title":"The role of adipose tissue immune cells in obesity and low-grade inflammation","volume":"222","author":"Mraz","year":"2014","journal-title":"J Endocrinol"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2018.00215","article-title":"Microglia responses to pro-inflammatory stimuli (LPS, IFN\u03b3+TNF\u03b1) and reprogramming by resolving cytokines (IL-4, IL-10)","volume":"12","author":"Lively","year":"2018","journal-title":"Front Cell Neurosci"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1113\/JP283259","article-title":"Sodium-glucose cotransporter 2 inhibitor ameliorates high fat diet-induced hypothalamic-pituitary-ovarian axis disorders","volume":"600","author":"Chen","year":"2022","journal-title":"J Physiol"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.3390\/nu13020520","article-title":"Hypothalamic inflammation as a potential pathophysiologic basis for the heterogeneity of clinical, hormonal, and metabolic presentation in PCOS","volume":"13","author":"Barlampa","year":"2021","journal-title":"Nutrients"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2022.03.009","article-title":"Polycystic ovary syndrome: a \u201crisk-enhancing\u201d factor for cardiovascular disease","volume":"117","author":"Guan","year":"2022","journal-title":"Fertil Steril"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmaa029","article-title":"Long-term cardiometabolic disease risk in women with PCOS: a systematic review and meta-analysis","volume":"26","author":"Wekker","year":"2020","journal-title":"Hum Reprod Update"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2022.02.028","article-title":"Subclinical cardiovascular disease and polycystic ovary syndrome","volume":"117","author":"Gomez","year":"2022","journal-title":"Fertil Steril"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1111\/cen.12068","article-title":"Diabetes and cardiovascular events in women with polycystic ovary syndrome: a 20-year retrospective cohort study","volume":"78","author":"Mani","year":"2013","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2010.06.092","article-title":"Ischemia-modified albumin and cardiovascular risk markers in polycystic ovary syndrome with or without insulin resistance","volume":"95","author":"Caglar","year":"2011","journal-title":"Fertil Steril"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1093\/ajh\/hpu251","article-title":"Hypertension in reproductive-aged women with polycystic ovary syndrome and association with obesity","volume":"28","author":"Joham","year":"2015","journal-title":"Am J Hypertens"},{"key":"B98","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1093\/humupd\/dmr001","article-title":"PCOS, coronary heart disease, stroke and the influence of obesity: a systematic review and meta-analysis","volume":"17","author":"de Groot","year":"2011","journal-title":"Hum Reprod Update"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.3390\/ijms150711324","article-title":"Endothelial dysfunction in chronic inflammatory diseases","volume":"15","author":"Steyers","year":"2014","journal-title":"Int J Mol Sci"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22083850","article-title":"Endothelial dysfunction, inflammation and coronary artery disease: potential biomarkers and promising therapeutical approaches","volume":"22","author":"Medina-Leyte","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B101","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s12978-018-0519-2","article-title":"A potential link between polycystic ovary syndrome and non-alcoholic fatty liver disease: an update meta-analysis","volume":"15","author":"Wu","year":"2018","journal-title":"Reprod Health"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/dep380","article-title":"Increased androgen bioavailability is associated with non-alcoholic fatty liver disease in women with polycystic ovary syndrome","volume":"25","author":"Vassilatou","year":"2010","journal-title":"Hum Reprod"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1111\/cen.14062","article-title":"Clinical prediction score of nonalcoholic fatty liver disease in adolescent girls with polycystic ovary syndrome (PCOS-HS index)","volume":"91","author":"Carreau","year":"2019","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgast-2020-000574","article-title":"From adolescent PCOS to adult MAFLD: opposing effects of randomised interventions","volume":"8","author":"de Zegher","year":"2021","journal-title":"BMJ Open Gastroenterol"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.2008.05740.x","article-title":"An association between non-alcoholic fatty liver disease and polycystic ovarian syndrome","volume":"24","author":"Brzozowska","year":"2009","journal-title":"J Gastroenterol Hepatol"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-017-0708-9","article-title":"Non-alcoholic fatty liver disease in women with polycystic ovary syndrome: systematic review and meta-analysis","volume":"40","author":"Rocha","year":"2017","journal-title":"J Endocrinol Invest"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2022.888194","article-title":"Key genes associated with non-alcoholic fatty liver disease and polycystic ovary syndrome","volume":"9","author":"Chen","year":"2022","journal-title":"Front Mol Biosci"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0048643","article-title":"Adipocyte dysfunction in a mouse model of polycystic ovary syndrome (PCOS): evidence of adipocyte hypertrophy and tissue-specific inflammation","volume":"7","author":"Marino","year":"2012","journal-title":"PloS One"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.24477","article-title":"Hyperandrogenism and insulin resistance contribute to hepatic steatosis and inflammation in female rat liver","volume":"9","author":"Zhang","year":"2018","journal-title":"Oncotarget"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2023.116604","article-title":"Low-dose spironolactone combats dyslipidemia and hepatic inflammation by modulating PCSK9 in rat model of polycystic ovarian syndrome","volume":"473","author":"Olaniyi","year":"2023","journal-title":"Toxicol Appl Pharmacol"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.3390\/medicina56030100","article-title":"Effect of DHT-induced hyperandrogenism on the pro-inflammatory cytokines in a rat model of polycystic ovary morphology","volume":"56","author":"Krishnan","year":"2020","journal-title":"Medicina (Kaunas)"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1125246","article-title":"The development of COVID-19 treatment","volume":"14","author":"Yuan","year":"2023","journal-title":"Front Immunol"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsbmb.2020.105770","article-title":"Coronavirus Disease 2019 (SARS-CoV-2) and polycystic ovarian disease: Is there a higher risk for these women","volume":"205","author":"Morgante","year":"2021","journal-title":"J Steroid Biochem Mol Biol"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1007\/s11154-022-09715-y","article-title":"Polycystic ovary syndrome and risks for COVID-19 infection: A comprehensive review: PCOS and COVID-19 relationship","volume":"23","author":"de Medeiros","year":"2022","journal-title":"Rev Endocr Metab Disord"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22094472","article-title":"SARS-coV-2 viral entry proteins in hyperandrogenemic female mice: implications for women with PCOS and COVID-19","volume":"22","author":"Huffman","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2007.11.022","article-title":"Risk of depression and other mental health disorders in women with polycystic ovary syndrome: a longitudinal study","volume":"91","author":"Kerchner","year":"2009","journal-title":"Fertil Steril"},{"key":"B117","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mcna.2022.09.001","article-title":"The role of inflammation in the pathophysiology of depression and suicidal behavior: implications for treatment","volume":"107","author":"Serafini","year":"2023","journal-title":"Med Clin North Am"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2016.167","article-title":"Therapeutic implications of brain-immune interactions: treatment in translation","volume":"42","author":"Miller","year":"2017","journal-title":"Neuropsychopharmacology"},{"key":"B119","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1007\/978-3-031-21054-9_16","article-title":"Increased inflammation and treatment of depression: from resistance to reuse, repurposing, and redesign","volume":"30","author":"Felger","year":"2023","journal-title":"Adv Neurobiol"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1097\/PSY.0b013e3181907c1b","article-title":"Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis","volume":"71","author":"Howren","year":"2009","journal-title":"Psychosom Med"},{"key":"B121","doi-asserted-by":"publisher","first-page":"41","DOI":"10.31887\/DCNS.2011.13.1\/rshelton","article-title":"Inflammation in depression: is adiposity a cause","volume":"13","author":"Shelton","year":"2011","journal-title":"Dialogues Clin Neurosci"},{"key":"B122","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/7854_2016_37","article-title":"Immune-to-brain communication pathways in inflammation-associated sickness and depression","volume":"31","author":"D\u2019Mello","year":"2017","journal-title":"Curr Top Behav Neurosci"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbi.2007.05.005","article-title":"Brain-immune communication pathways","volume":"21","author":"Quan","year":"2007","journal-title":"Brain Behav Immun"},{"key":"B124","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.pnpbp.2015.11.012","article-title":"Innate and adaptive immunity in the development of depression: An update on current knowledge and technological advances","volume":"66","author":"Haapakoski","year":"2016","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M410858200","article-title":"p38 MAPK activation elevates serotonin transport activity via a trafficking-independent, protein phosphatase 2A-dependent process","volume":"280","author":"Zhu","year":"2005","journal-title":"J Biol Chem"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2010.116","article-title":"Interleukin-1 receptor activation by systemic lipopolysaccharide induces behavioral despair linked to MAPK regulation of CNS serotonin transporters","volume":"35","author":"Zhu","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1016\/s0015-0282(03)00734-9","article-title":"The importance of insulin resistance in polycystic ovary syndrome","volume":"80","author":"Goodarzi","year":"2003","journal-title":"Fertil Steril"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2006-2725","article-title":"Abdominal fat quantity and distribution in women with polycystic ovary syndrome and extent of its relation to insulin resistance","volume":"92","author":"Carmina","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"B129","doi-asserted-by":"publisher","first-page":"R79","DOI":"10.1530\/REP-18-0583","article-title":"Obesity induces ovarian inflammation and reduces oocyte quality","volume":"158","author":"Snider","year":"2019","journal-title":"Reproduction"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1172\/JCI29069","article-title":"Inflammation and insulin resistance","volume":"116","author":"Shoelson","year":"2006","journal-title":"J Clin Invest"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.3109\/09513590.2012.683082","article-title":"Mediators of chronic inflammation in polycystic ovarian syndrome","volume":"28","author":"Deligeoroglou","year":"2012","journal-title":"Gynecol Endocrinol"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1530\/REP-14-0435","article-title":"Adipose tissue dysfunction, adipokines, and low-grade chronic inflammation in polycystic ovary syndrome","volume":"149","author":"Spritzer","year":"2015","journal-title":"Reproduction"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1172\/JCI10934","article-title":"Insulin\/IGF-1 and TNF-alpha stimulate phosphorylation of IRS-1 at inhibitory Ser307 via distinct pathways","volume":"107","author":"Rui","year":"2001","journal-title":"J Clin Invest"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(18)42251-X","article-title":"Transcriptional repression of the C\/EBP-alpha and GLUT4 genes in 3T3-L1 adipocytes by tumor necrosis factor-alpha. Regulations is coordinate and independent of protein synthesis","volume":"267","author":"Stephens","year":"1992","journal-title":"J Biol Chem"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1002\/mrd.22231","article-title":"Diet-induced obesity alters immune cell infiltration and expression of inflammatory cytokine genes in mouse ovarian and peri-ovarian adipose depot tissues","volume":"80","author":"Nteeba","year":"2013","journal-title":"Mol Reprod Dev"},{"key":"B136","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome","volume":"81","author":"Chang","year":"2004","journal-title":"Fertil Steril"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.55.03.06.db05-0453","article-title":"Enhanced mitogenic signaling in skeletal muscle of women with polycystic ovary syndrome","volume":"55","author":"Corbould","year":"2006","journal-title":"Diabetes"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1042\/BJ20082176","article-title":"Insulin resistance in polycystic ovary syndrome is associated with defective regulation of ERK1\/2 by insulin in skeletal muscle in vivo","volume":"418","author":"Rajkhowa","year":"2009","journal-title":"Biochem J"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24043140","article-title":"Insulin metabolism in polycystic ovary syndrome: secretion, signaling, and clearance","volume":"24","author":"Herman","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B140","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.steroids.2011.10.013","article-title":"Tissue physiology and pathology of aromatase","volume":"77","author":"Stocco","year":"2012","journal-title":"Steroids"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2005-1696","article-title":"Reactive oxygen species-induced oxidative stress in the development of insulin resistance and hyperandrogenism in polycystic ovary syndrome","volume":"91","author":"Gonz\u00e1lez","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2022.04.234","article-title":"Immune regulation in polycystic ovary syndrome","volume":"531","author":"Luan","year":"2022","journal-title":"Clin Chim Acta"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaa951","article-title":"TLR4-associated IRF-7 and NF\u03baB signaling act as a molecular link between androgen and metformin activities and cytokine synthesis in the PCOS endometrium","volume":"106","author":"Hu","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1038\/ijo.2017.116","article-title":"High-free androgen index is associated with increased risk of non-alcoholic fatty liver disease in women with polycystic ovary syndrome, independent of obesity and insulin resistance","volume":"41","author":"Cai","year":"2017","journal-title":"Int J Obes (Lond)"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-017-0762-3","article-title":"Androgen excess and metabolic disorders in women with PCOS: beyond the body mass index","volume":"41","author":"Condorelli","year":"2018","journal-title":"J Endocrinol Invest"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1016\/j.scitotenv.2020.141049","article-title":"Exposure to hyperandrogen drives ovarian dysfunction and fibrosis by activating the NLRP3 inflammasome in mice","volume":"745","author":"Wang","year":"2020","journal-title":"Sci Total Environ"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.27501","article-title":"Dehydroepiandrosterone stimulates inflammation and impairs ovarian functions of polycystic ovary syndrome","volume":"234","author":"Li","year":"2019","journal-title":"J Cell Physiol"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2013-4109","article-title":"Hyperandrogenism induces a proinflammatory TNF\u03b1 response to glucose ingestion in a receptor-dependent fashion","volume":"99","author":"Gonz\u00e1lez","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.00416.2011","article-title":"Hyperandrogenism sensitizes mononuclear cells to promote glucose-induced inflammation in lean reproductive-age women","volume":"302","author":"Gonz\u00e1lez","year":"2012","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.3390\/biom12091299","article-title":"Progesterone as an anti-inflammatory drug and immunomodulator: new aspects in hormonal regulation of the inflammation","volume":"12","author":"Fedotcheva","year":"2022","journal-title":"Biomolecules"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.1016\/j.endmts.2021.100110","article-title":"COVID-19 and Progesterone: Part 2. Unraveling High Severity, Immunity Patterns, Immunity grading, Progesterone and its potential clinical use","volume":"5","author":"Shah","year":"2021","journal-title":"Endocr Metab Sci"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1016\/j.endmts.2021.100109","article-title":"COVID-19 and Progesterone: Part 1. SARS-CoV-2, Progesterone and its potential clinical use","volume":"5","author":"Shah","year":"2021","journal-title":"Endocr Metab Sci"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.940675","article-title":"Associations between COVID-19 infection and sex steroid hormones","volume":"13","author":"Cai","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.1210\/endocr\/bqaa127","article-title":"Estradiol, progesterone, immunomodulation, and COVID-19 outcomes","volume":"161","author":"Mauvais-Jarvis","year":"2020","journal-title":"Endocrinology"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.1210\/me.2015-1122","article-title":"Progesterone and the repression of myometrial inflammation: the roles of MKP-1 and the AP-1 system","volume":"29","author":"Lei","year":"2015","journal-title":"Mol Endocrinol"},{"key":"B156","doi-asserted-by":"publisher","first-page":"R719","DOI":"10.1152\/ajpregu.00152.2020","article-title":"Progesterone-induced blocking factor improves blood pressure, inflammation, and pup weight in response to reduced uterine perfusion pressure (RUPP)","volume":"320","author":"Cottrell","year":"2021","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.3390\/biom12081029","article-title":"Progesterone suppresses uterine contraction by reducing odontogenic porphyromonas gingivalis induced chronic inflammation in mice","volume":"12","author":"Teraoka","year":"2022","journal-title":"Biomolecules"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.3390\/biom12030422","article-title":"Progesterone attenuates SIRT1-deficiency-mediated pre-eclampsia","volume":"12","author":"Pei","year":"2022","journal-title":"Biomolecules"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsbmb.2013.02.008","article-title":"Progesterone, inflammation and preterm labor","volume":"139","author":"Pa\u0159\u00edzek","year":"2014","journal-title":"J Steroid Biochem Mol Biol"},{"key":"B160","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222011039","article-title":"Key to life: physiological role and clinical implications of progesterone","volume":"22","author":"Nagy","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.1210\/er.2007-0001","article-title":"The complex role of estrogens in inflammation","volume":"28","author":"Straub","year":"2007","journal-title":"Endocr Rev"},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19030859","article-title":"Estrogen, angiogenesis, immunity and cell metabolism: solving the puzzle","volume":"19","author":"Trenti","year":"2018","journal-title":"Int J Mol Sci"},{"key":"B163","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.11681","article-title":"Metabolic, hormonal, immunologic, and genetic factors associated with the incidence of thyroid disorders in polycystic ovarian syndrome patients","volume":"12","author":"Singh","year":"2020","journal-title":"Cureus"},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2020.586667","article-title":"The microbiota of the human mammary ecosystem","volume":"10","author":"Fern\u00e1ndez","year":"2020","journal-title":"Front Cell Infect Microbiol"},{"key":"B165","doi-asserted-by":"publisher","DOI":"10.1038\/nm.4358","article-title":"Gut microbiome and serum metabolome alterations in obesity and after weight-loss intervention","volume":"23","author":"Liu","year":"2017","journal-title":"Nat Med"},{"key":"B166","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/nature11450","article-title":"A metagenome-wide association study of gut microbiota in type 2 diabetes","volume":"490","author":"Qin","year":"2012","journal-title":"Nature"},{"key":"B167","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1038\/s41467-017-00900-1","article-title":"The gut microbiome in atherosclerotic cardiovascular disease","volume":"8","author":"Jie","year":"2017","journal-title":"Nat Commun"},{"key":"B168","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2021.105840","article-title":"The role of microbiota-gut-brain axis in neuropsychiatric and neurological disorders","volume":"172","author":"Soca\u0142a","year":"2021","journal-title":"Pharmacol Res"},{"key":"B169","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1038\/s41591-022-01779-2","article-title":"Targeting the gut and tumor microbiota in cancer","volume":"28","author":"Park","year":"2022","journal-title":"Nat Med"},{"key":"B170","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0168390","article-title":"Alterations in gut microbiome composition and barrier function are associated with reproductive and metabolic defects in women with polycystic ovary syndrome (PCOS): A pilot study","volume":"12","author":"Lindheim","year":"2017","journal-title":"PloS One"},{"key":"B171","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2017.00324","article-title":"Dysbiosis of gut microbiota associated with clinical parameters in polycystic ovary syndrome","volume":"8","author":"Liu","year":"2017","journal-title":"Front Microbiol"},{"key":"B172","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2017-02153","article-title":"Gut microbial diversity in women with polycystic ovary syndrome correlates with hyperandrogenism","volume":"103","author":"Torres","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"B173","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-019-0509-0","article-title":"Gut microbiota-bile acid-interleukin-22 axis orchestrates polycystic ovary syndrome","volume":"25","author":"Qi","year":"2019","journal-title":"Nat Med"},{"key":"B174","doi-asserted-by":"publisher","DOI":"10.1159\/000490615","article-title":"The gut microbiota and healthy aging: A mini-review","volume":"64","author":"Kim","year":"2018","journal-title":"Gerontology"},{"key":"B175","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.jaut.2018.05.008","article-title":"Connecting the immune system, systemic chronic inflammation and the gut microbiome: The role of sex","volume":"92","author":"Rizzetto","year":"2018","journal-title":"J Autoimmun"},{"key":"B176","doi-asserted-by":"publisher","DOI":"10.1016\/j.mehy.2012.04.016","article-title":"Dysbiosis of Gut Microbiota (DOGMA)\u2013a novel theory for the development of Polycystic Ovarian Syndrome","volume":"79","author":"Tremellen","year":"2012","journal-title":"Med Hypotheses"},{"key":"B177","doi-asserted-by":"publisher","first-page":"14","DOI":"10.5468\/ogs.21185","article-title":"A narrative review of the role of gastrointestinal dysbiosis in the pathogenesis of polycystic ovary syndrome","volume":"65","author":"Parker","year":"2022","journal-title":"Obstet Gynecol Sci"},{"key":"B178","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s40168-021-01046-5","article-title":"Androgen-induced gut dysbiosis disrupts glucolipid metabolism and endocrinal functions in polycystic ovary syndrome","volume":"9","author":"Han","year":"2021","journal-title":"Microbiome"},{"key":"B179","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2018.1441664","article-title":"Prenatal androgen exposure causes hypertension and gut microbiota dysbiosis","volume":"9","author":"Sherman","year":"2018","journal-title":"Gut Microbes"},{"key":"B180","doi-asserted-by":"publisher","DOI":"10.1210\/en.2016-1317","article-title":"Neonatal androgen exposure causes persistent gut microbiota dysbiosis related to metabolic disease in adult female rats","volume":"157","author":"Moreno-Indias","year":"2016","journal-title":"Endocrinology"},{"key":"B181","doi-asserted-by":"publisher","DOI":"10.1038\/s42255-024-01041-8","article-title":"The microbial metabolite agmatine acts as an FXR agonist to promote polycystic ovary syndrome in female mice","volume":"6","author":"Yun","year":"2024","journal-title":"Nat Metab"},{"key":"B182","doi-asserted-by":"publisher","DOI":"10.1038\/nature12726","article-title":"Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation","volume":"504","author":"Arpaia","year":"2013","journal-title":"Nature"},{"key":"B183","doi-asserted-by":"publisher","DOI":"10.1126\/science.1241165","article-title":"The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis","volume":"341","author":"Smith","year":"2013","journal-title":"Science"},{"key":"B184","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2015.09.007","article-title":"Dietary fatty acids directly impact central nervous system autoimmunity via the small intestine","volume":"43","author":"Haghikia","year":"2015","journal-title":"Immunity"},{"key":"B185","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-023-01487-9","article-title":"Short-chain fatty acid-butyric acid ameliorates granulosa cells inflammation through regulating METTL3-mediated N6-methyladenosine modification of FOSL2 in polycystic ovarian syndrome","volume":"15","author":"Liu","year":"2023","journal-title":"Clin Epigenetics"},{"key":"B186","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m2511","article-title":"Health effects of vitamin and mineral supplements","volume":"369","author":"Zhang","year":"2020","journal-title":"BMJ"},{"key":"B187","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.fertnstert.2014.04.046","article-title":"Role of vitamin D in ovarian physiology and its implication in reproduction: a systematic review","volume":"102","author":"Irani","year":"2014","journal-title":"Fertil Steril"},{"key":"B188","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2021.611351","article-title":"Low vitamin D level in saudi women with polycystic ovary syndrome","volume":"8","author":"Bindayel","year":"2021","journal-title":"Front Nutr"},{"key":"B189","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1530\/EJE-11-1070","article-title":"Parameters for calcium metabolism in women with polycystic ovary syndrome who undergo clomiphene citrate stimulation: a prospective cohort study","volume":"166","author":"Ott","year":"2012","journal-title":"Eur J Endocrinol"},{"key":"B190","doi-asserted-by":"publisher","DOI":"10.1007\/s00404-009-0958-7","article-title":"Serum 25-hydroxyvitamin D concentrations in obese and non-obese women with polycystic ovary syndrome","volume":"280","author":"Yildizhan","year":"2009","journal-title":"Arch Gynecol Obstet"},{"key":"B191","doi-asserted-by":"publisher","DOI":"10.1055\/s-2006-948308","article-title":"Low serum 25-hydroxyvitamin D concentrations are associated with insulin resistance and obesity in women with polycystic ovary syndrome","volume":"114","author":"Hahn","year":"2006","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"B192","doi-asserted-by":"publisher","DOI":"10.3390\/nu7064555","article-title":"Serum vitamin D levels and polycystic ovary syndrome: A systematic review and meta-analysis","volume":"7","author":"He","year":"2015","journal-title":"Nutrients"},{"key":"B193","doi-asserted-by":"publisher","DOI":"10.23736\/S0391-1977.18.02824-9","article-title":"Associations between vitamin D levels and polycystic ovary syndrome phenotypes","volume":"44","author":"Davis","year":"2019","journal-title":"Minerva Endocrinol"},{"key":"B194","doi-asserted-by":"publisher","DOI":"10.3390\/nu12072097","article-title":"Immunologic effects of vitamin D on human health and disease","volume":"12","author":"Charoenngam","year":"2020","journal-title":"Nutrients"},{"key":"B195","doi-asserted-by":"publisher","DOI":"10.3390\/biom11111624","article-title":"The effects of vitamin D on immune system and inflammatory diseases","volume":"11","author":"Ao","year":"2021","journal-title":"Biomolecules"},{"key":"B196","doi-asserted-by":"publisher","DOI":"10.21037\/apm-20-2201","article-title":"Vitamin D improves levels of hormonal, oxidative stress and inflammatory parameters in polycystic ovary syndrome: a meta-analysis study","volume":"10","author":"Zhao","year":"2021","journal-title":"Ann Palliat Med"},{"key":"B197","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.ctcp.2016.11.008","article-title":"Effect of vitamin D supplementation on polycystic ovary syndrome: A systematic review and meta-analysis of randomized controlled trials","volume":"26","author":"Fang","year":"2017","journal-title":"Complement Ther Clin Pract"},{"key":"B198","doi-asserted-by":"publisher","DOI":"10.1055\/s-0044-101355","article-title":"The effects of vitamin D supplementation on biomarkers of inflammation and oxidative stress among women with polycystic ovary syndrome: A systematic review and meta-analysis of randomized controlled trials","volume":"50","author":"Akbari","year":"2018","journal-title":"Horm Metab Res"},{"key":"B199","doi-asserted-by":"publisher","DOI":"10.1007\/BF03345785","article-title":"The effect of vitamin D replacement therapy on insulin resistance and androgen levels in women with polycystic ovary syndrome","volume":"33","author":"Selimoglu","year":"2010","journal-title":"J Endocrinol Invest"},{"key":"B200","doi-asserted-by":"publisher","DOI":"10.1089\/ars.2011.4145","article-title":"The role of selenium in inflammation and immunity: from molecular mechanisms to therapeutic opportunities","volume":"16","author":"Huang","year":"2012","journal-title":"Antioxid Redox Signal"},{"key":"B201","doi-asserted-by":"publisher","DOI":"10.1007\/s10787-020-00690-x","article-title":"Selenium and selenoproteins: it\u2019s role in regulation of inflammation","volume":"28","author":"Hariharan","year":"2020","journal-title":"Inflammopharmacology"},{"key":"B202","doi-asserted-by":"publisher","DOI":"10.1055\/a-0890-6823","article-title":"Selenium and polycystic ovary syndrome; current knowledge and future directions: A systematic review","volume":"51","author":"Hajizadeh-Sharafabad","year":"2019","journal-title":"Horm Metab Res"},{"key":"B203","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2008.09.025","article-title":"Interaction of glutathione peroxidase-1 and selenium in endemic dilated cardiomyopathy","volume":"399","author":"Lei","year":"2009","journal-title":"Clin Chim Acta"},{"key":"B204","doi-asserted-by":"publisher","DOI":"10.1007\/s00592-012-0440-z","article-title":"Polymorphisms in the Selenoprotein S gene and subclinical cardiovascular disease in the Diabetes Heart Study","volume":"50","author":"Cox","year":"2013","journal-title":"Acta Diabetol"},{"key":"B205","doi-asserted-by":"publisher","DOI":"10.1111\/jam.14150","article-title":"Effects of selenium on oxidative damage and antioxidant enzymes of eukaryotic cells: wine Saccharomyces cerevisiae","volume":"126","author":"Talbi","year":"2019","journal-title":"J Appl Microbiol"},{"key":"B206","doi-asserted-by":"publisher","DOI":"10.3390\/antiox11020251","article-title":"The role of selenium in pathologies: an updated review","volume":"11","author":"Barchielli","year":"2022","journal-title":"Antioxidants (Basel)"},{"key":"B207","doi-asserted-by":"publisher","DOI":"10.1007\/s12011-023-03579-2","article-title":"Therapeutic potential of selenium nanoparticles on letrozole-induced polycystic ovarian syndrome in female wistar rats","volume":"201","author":"Butt","year":"2023","journal-title":"Biol Trace Elem Res"},{"key":"B208","doi-asserted-by":"publisher","DOI":"10.1080\/13510002.2022.2160569","article-title":"Novel insights into the synergistic effects of selenium nanoparticles and metformin treatment of letrozole - induced polycystic ovarian syndrome: targeting PI3K\/Akt signalling pathway, redox status and mitochondrial dysfunction in ovarian tissue","volume":"28","author":"Rabah","year":"2023","journal-title":"Redox Rep"},{"key":"B209","doi-asserted-by":"publisher","DOI":"10.1007\/s12011-023-03616-0","article-title":"Selenium nanoparticles modulate steroidogenesis-related genes and improve ovarian functions via regulating androgen receptors expression in polycystic ovary syndrome rat model","volume":"201","author":"Abdallah","year":"2023","journal-title":"Biol Trace Elem Res"},{"key":"B210","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s12902-023-01286-6","article-title":"Effects of selenium supplementation on Polycystic Ovarian Syndrome: a systematic review and meta-analysis on randomized clinical trials","volume":"23","author":"Zhao","year":"2023","journal-title":"BMC Endocr Disord"},{"key":"B211","doi-asserted-by":"publisher","DOI":"10.1080\/09513590.2016.1203893","article-title":"Evaluation of cardiac risk marker levels in obese and non-obese patients with polycystic ovaries","volume":"33","author":"Elci","year":"2017","journal-title":"Gynecol Endocrinol"},{"key":"B212","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2008.03.039","article-title":"Polycystic ovary syndrome is associated with elevated plasma soluble CD40 ligand, a marker of coronary artery disease","volume":"91","author":"Oktem","year":"2009","journal-title":"Fertil Steril"},{"key":"B213","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.0000089561.87997.CF","article-title":"Homocysteine, a proinflammatory and proatherosclerotic factor: role of intracellular reactive oxygen species","volume":"93","author":"Schini-Kerth","year":"2003","journal-title":"Circ Res"},{"key":"B214","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.0000087642.01082.E4","article-title":"Homocysteine mediated expression and secretion of monocyte chemoattractant protein-1 and interleukin-8 in human monocytes","volume":"93","author":"Zeng","year":"2003","journal-title":"Circ Res"},{"key":"B215","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.103.22.2717","article-title":"Homocysteine induces expression and secretion of monocyte chemoattractant protein-1 and interleukin-8 in human aortic endothelial cells: implications for vascular disease","volume":"103","author":"Poddar","year":"2001","journal-title":"Circulation"},{"key":"B216","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-200308000-00016","article-title":"Intracellular redox status modulates monocyte chemoattractant protein-1 expression stimulated by homocysteine in endothelial cells","volume":"42","author":"Zhang","year":"2003","journal-title":"J Cardiovasc Pharmacol"},{"key":"B217","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.121.316091","article-title":"Monocyte-chemoattractant protein-1 levels in human atherosclerotic lesions associate with plaque vulnerability","volume":"41","author":"Georgakis","year":"2021","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B218","doi-asserted-by":"publisher","DOI":"10.1161\/01.atv.17.2.317","article-title":"Macrophages isolated from human atherosclerotic plaques produce IL-8, and oxysterols may have a regulatory function for IL-8 production","volume":"17","author":"Liu","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B219","doi-asserted-by":"publisher","DOI":"10.1177\/1933719118756772","article-title":"Elevated CD14(++)CD16(+) monocytes in hyperhomocysteinemia-associated insulin resistance in polycystic ovary syndrome","volume":"25","author":"Zhang","year":"2018","journal-title":"Reprod Sci"},{"key":"B220","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.bbrc.2018.04.078","article-title":"Hyperhomocysteinemia and hyperandrogenemia share PCSK9-LDLR pathway to disrupt lipid homeostasis in PCOS","volume":"503","author":"Mondal","year":"2018","journal-title":"Biochem Biophys Res Commun"},{"key":"B221","doi-asserted-by":"publisher","DOI":"10.1210\/en.2017-00039","article-title":"Hyperhomocysteinemia promotes insulin resistance and adipose tissue inflammation in PCOS mice through modulating M2 macrophage polarization via estrogen suppression","volume":"158","author":"Qi","year":"2017","journal-title":"Endocrinology"},{"key":"B222","doi-asserted-by":"publisher","first-page":"S65","DOI":"10.5694\/mja11.10915","article-title":"Assessment and management of polycystic ovary syndrome: summary of an evidence-based guideline","volume":"195","author":"Teede","year":"2011","journal-title":"Med J Aust"},{"key":"B223","doi-asserted-by":"publisher","DOI":"10.3390\/nu14194147","article-title":"Does the ketogenic diet improve the quality of ovarian function in obese women","volume":"14","author":"Magagnini","year":"2022","journal-title":"Nutrients"},{"key":"B224","doi-asserted-by":"publisher","DOI":"10.3390\/nu11102278","article-title":"Adherence to the mediterranean diet, dietary patterns and body composition in women with polycystic ovary syndrome (PCOS)","volume":"11","author":"Barrea","year":"2019","journal-title":"Nutrients"},{"key":"B225","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s12967-021-02817-2","article-title":"Eight-hour time-restricted feeding improves endocrine and metabolic profiles in women with anovulatory polycystic ovary syndrome","volume":"19","author":"Li","year":"2021","journal-title":"J Transl Med"},{"key":"B226","doi-asserted-by":"publisher","DOI":"10.1093\/advances\/nmab141","article-title":"Nutritional supplements and complementary therapies in polycystic ovary syndrome","volume":"13","author":"Alesi","year":"2022","journal-title":"Adv Nutr"},{"key":"B227","doi-asserted-by":"publisher","DOI":"10.1111\/cen.12451","article-title":"The effects of folate supplementation on inflammatory factors and biomarkers of oxidative stress in overweight and obese women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled clinical trial","volume":"81","author":"Bahmani","year":"2014","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B228","doi-asserted-by":"publisher","DOI":"10.5001\/omj.2018.88","article-title":"The effects of omega-3 and vitamin E co-supplementation on carotid intima-media thickness and inflammatory factors in patients with polycystic ovary syndrome","volume":"33","author":"Talari","year":"2018","journal-title":"Oman Med J"},{"key":"B229","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1080\/09513590.2017.1418852","article-title":"Effects of myo-inositol, gymnemic acid, and L-methylfolate in polycystic ovary syndrome patients","volume":"34","author":"Stracquadanio","year":"2018","journal-title":"Gynecol Endocrinol"},{"key":"B230","doi-asserted-by":"publisher","DOI":"10.1007\/s00404-019-05194-w","article-title":"The impact of a standardized micronutrient supplementation on PCOS-typical parameters: a randomized controlled trial","volume":"300","author":"Hager","year":"2019","journal-title":"Arch Gynecol Obstet"},{"key":"B231","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2018.05.004","article-title":"Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"110","author":"Teede","year":"2018","journal-title":"Fertil Steril"},{"key":"B232","doi-asserted-by":"publisher","DOI":"10.1155\/2023\/3924018","article-title":"The effect of exercise on inflammatory markers in PCOS women: A systematic review and meta-analysis of randomized trials","volume":"2023","author":"Hafizi Moori","year":"2023","journal-title":"Int J Clin Pract"},{"key":"B233","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/deac047","article-title":"High-intensity training elicits greater improvements in cardio-metabolic and reproductive outcomes than moderate-intensity training in women with polycystic ovary syndrome: a randomized clinical trial","volume":"37","author":"Patten","year":"2022","journal-title":"Hum Reprod"},{"key":"B234","doi-asserted-by":"publisher","first-page":"CD003053","DOI":"10.1002\/14651858.CD003053.pub5","article-title":"Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility","author":"Tang","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"B235","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj.EJ18-0567","article-title":"Inulin and metformin ameliorate polycystic ovary syndrome via anti-inflammation and modulating gut microbiota in mice","volume":"66","author":"Xue","year":"2019","journal-title":"Endocr J"},{"key":"B236","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.891297","article-title":"Effects of Bu Shen Hua Zhuo formula on the LPS\/TLR4 pathway and gut microbiota in rats with letrozole-induced polycystic ovary syndrome","volume":"13","author":"Wang","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B237","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.00575","article-title":"Guizhi fuling wan, chinese herbal medicine, ameliorates insulin sensitivity in PCOS model rats with insulin resistance via remodeling intestinal homeostasis","volume":"11","author":"Zhu","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B238","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.670054","article-title":"Shaoyao-gancao decoction ameliorates the inflammation state in polycystic ovary syndrome rats via remodeling gut microbiota and suppressing the TLR4\/NF-\u03baB pathway","volume":"12","author":"Chang","year":"2021","journal-title":"Front Pharmacol"},{"key":"B239","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgad463","article-title":"Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"108","author":"Teede","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"key":"B240","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2023.102162","article-title":"Efficacy and safety of anti-androgens in the management of polycystic ovary syndrome: a systematic review and meta-analysis of randomised controlled trials","volume":"63","author":"Alesi","year":"2023","journal-title":"EClinicalMedicine"},{"key":"B241","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1186\/s12902-022-01143-y","article-title":"Low-dose spironolactone ameliorates adipose tissue inflammation and apoptosis in letrozole-induced PCOS rat model","volume":"22","author":"Areloegbe","year":"2022","journal-title":"BMC Endocr Disord"},{"key":"B242","doi-asserted-by":"publisher","first-page":"e29678","DOI":"10.1097\/MD.0000000000029678","article-title":"Assessment of neutrophil to lymphocyte ratio, C-reactive protein, mean platelet volume in obese, and nonobese patients with polycystic ovary syndrome","volume":"101","author":"Liu","year":"2022","journal-title":"Med (Baltimore)"},{"key":"B243","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11102791","article-title":"Inflammatory and anti-inflammatory parameters in PCOS patients depending on body mass index: A case-control study","volume":"11","author":"Vasyukova","year":"2023","journal-title":"Biomedicines"},{"key":"B244","doi-asserted-by":"publisher","DOI":"10.26355\/eurrev_202205_28845","article-title":"Effect of aerobic exercise on inflammatory markers in polycystic ovary syndrome: a randomized controlled trial","volume":"26","author":"Elbandrawy","year":"2022","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"B245","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1177\/0003319709361198","article-title":"Serum high-sensitivity C-reactive protein and homocysteine changes during hormonal therapy in women with polycystic ovary syndrome: a prospective, matched study","volume":"61","author":"Makedos","year":"2010","journal-title":"Angiology"},{"key":"B246","doi-asserted-by":"publisher","first-page":"e74713","DOI":"10.7554\/eLife.74713","article-title":"Metformin abrogates pathological TNF-\u03b1-producing B cells through mTOR-dependent metabolic reprogramming in polycystic ovary syndrome","volume":"11","author":"Xiao","year":"2022","journal-title":"Elife"},{"key":"B247","doi-asserted-by":"publisher","DOI":"10.1021\/acsptsci.1c00167","article-title":"Metformin for cardiovascular protection, inflammatory bowel disease, osteoporosis, periodontitis, polycystic ovarian syndrome, neurodegeneration, cancer, inflammation and senescence: what is next","volume":"4","author":"Ala","year":"2021","journal-title":"ACS Pharmacol Transl Sci"},{"key":"B248","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/deac067","article-title":"At the crossroads of fertility and metabolism: the importance of AMPK-dependent signaling in female infertility associated with hyperandrogenism","volume":"37","author":"Froment","year":"2022","journal-title":"Hum Reprod"},{"key":"B249","doi-asserted-by":"publisher","DOI":"10.1016\/j.steroids.2011.11.014","article-title":"Medical management of metabolic dysfunction in PCOS","volume":"77","author":"Duleba","year":"2012","journal-title":"Steroids"},{"key":"B250","doi-asserted-by":"publisher","first-page":"19927","DOI":"10.1038\/s41598-022-24467-0","article-title":"A meta-analysis of effects of vitamin E supplementation alone and in combination with omega-3 or magnesium on polycystic ovary syndrome","volume":"12","author":"Heidari","year":"2022","journal-title":"Sci Rep"},{"key":"B251","doi-asserted-by":"publisher","DOI":"10.1016\/s0015-0282(02)03133-3","article-title":"N-acetyl-cysteine treatment improves insulin sensitivity in women with polycystic ovary syndrome","volume":"77","author":"Fulghesu","year":"2002","journal-title":"Fertil Steril"},{"key":"B252","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1080\/01443615.2019.1604644","article-title":"Efficacy of combination therapy of inositols, antioxidants and vitamins in obese and non-obese women with polycystic ovary syndrome: an observational study","volume":"40","author":"Advani","year":"2020","journal-title":"J Obstet Gynaecol"},{"key":"B253","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/817849","article-title":"N-acetylcysteine for polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled clinical trials","volume":"2015","author":"Thakker","year":"2015","journal-title":"Obstet Gynecol Int"},{"key":"B254","doi-asserted-by":"publisher","DOI":"10.1186\/s12958-023-01055-z","article-title":"Inositol is an effective and safe treatment in polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials","volume":"21","author":"Greff","year":"2023","journal-title":"Reprod Biol Endocrinol"},{"key":"B255","doi-asserted-by":"publisher","DOI":"10.1080\/09513590.2018.1462320","article-title":"Alpha lipoic acid in obstetrics and gynecology","volume":"34","author":"Di Tucci","year":"2018","journal-title":"Gynecol Endocrinol"},{"key":"B256","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22042048","article-title":"Microbiome and PCOS: state-of-art and future aspects","volume":"22","author":"Giampaolino","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B257","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0217495","article-title":"ETA-mediated anti-TNF-\u03b1 therapy ameliorates the phenotype of PCOS model induced by letrozole","volume":"14","author":"Lang","year":"2019","journal-title":"PloS One"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1470283\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T05:10:31Z","timestamp":1734585031000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1470283\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,19]]},"references-count":257,"alternative-id":["10.3389\/fimmu.2024.1470283"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2024.1470283","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,19]]},"article-number":"1470283"}}